PAVmed Other Current Liab vs Cash And Short Term Investments Analysis
PAVMZ Stock | USD 0.03 0.00 0.00% |
PAVmed Series financial indicator trend analysis is much more than just breaking down PAVmed Series Z prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PAVmed Series Z is a good investment. Please check the relationship between PAVmed Series Other Current Liab and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Other Current Liab vs Cash And Short Term Investments
Other Current Liab vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PAVmed Series Z Other Current Liab account and Cash And Short Term Investments. At this time, the significance of the direction appears to have very week relationship.
The correlation between PAVmed Series' Other Current Liab and Cash And Short Term Investments is 0.24. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of PAVmed Series Z, assuming nothing else is changed. The correlation between historical values of PAVmed Series' Other Current Liab and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of PAVmed Series Z are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Current Liab i.e., PAVmed Series' Other Current Liab and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.24 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Other Current Liab
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of PAVmed Series Z balance sheet. This account contains PAVmed Series investments that will expire within one year. These investments include stocks and bonds that can be liquidated by PAVmed Series Z fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from PAVmed Series' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PAVmed Series Z current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, PAVmed Series' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 29.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 11.99 in 2024.
PAVmed Series fundamental ratios Correlations
Click cells to compare fundamentals
PAVmed Series Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PAVmed Series fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.2M | 19.8M | 87.0M | 54.0M | 33.1M | 23.6M | |
Other Current Liab | 1.4M | (15.0M) | 4.3M | 3.7M | 6.6M | 7.0M | |
Total Current Liabilities | 11.9M | 20.0M | 7.6M | 41.2M | 54.2M | 56.9M | |
Total Stockholder Equity | (3.8M) | 1.9M | 61.7M | (9.7M) | (53.8M) | (51.1M) | |
Net Debt | 1.9M | (2.3M) | (77.3M) | (3.1M) | 29.1M | 30.5M | |
Retained Earnings | (53.7M) | (88.3M) | (138.9M) | (228.2M) | (294.4M) | (279.7M) | |
Cash | 6.2M | 17.3M | 77.3M | 39.7M | 19.6M | 18.9M | |
Cash And Short Term Investments | 6.2M | 17.3M | 77.3M | 39.7M | 19.6M | 18.9M | |
Liabilities And Stockholders Equity | 7.2M | 19.8M | 87.0M | 54.0M | 33.1M | 23.6M | |
Capital Surpluse | 14.0M | 32.6M | 47.6M | 87.6M | 100.7M | 105.7M | |
Other Current Assets | 328.3B | 1.7M | 5.2M | 3.9M | 4.3M | 4.0M | |
Other Stockholder Equity | 47.6M | 87.6M | 198.1M | 215.9M | 237.6M | 249.5M | |
Total Liab | 11.9M | 20.3M | 7.6M | 43.0M | 57.1M | 60.0M | |
Total Current Assets | 6.5M | 18.9M | 82.6M | 43.9M | 24.5M | 20.8M | |
Common Stock | 40.5K | 64K | 86K | 95K | 9K | 8.6K | |
Accounts Payable | 2.4M | 3.0M | 3.3M | 2.7M | 1.8M | 2.1M | |
Non Current Assets Total | 692.9K | 837K | 4.3M | 10.1M | 8.6M | 9.1M | |
Common Stock Shares Outstanding | 2.0M | 3.2M | 5.2M | 5.9M | 7.2M | 7.6M | |
Non Current Liabilities Total | 10.5M | 300K | 4.3B | 1.8M | 3.0M | 2.8M | |
Short Long Term Debt Total | 7.9M | 8.1M | 15.0M | 36.6M | 48.7M | 51.2M | |
Net Invested Capital | 2.0M | 14.3M | 59.2M | 21.3M | (12.6M) | (12.0M) | |
Net Working Capital | (5.3M) | (1.0M) | 75.1M | 2.7M | (29.7M) | (28.2M) | |
Capital Stock | 2.3M | 2.6M | 2.5M | 2.8M | 3.0M | 2.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.